Get started
Author

Feng Ziding

Observed names: Feng, Ziding, Ziding Feng
Observed institution: Fred Hutch Cancer Center
OpenAlex ID: A5113818399
Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis
2026 · Amit G. Singal, Qingchun Jin, et al. · Hepatology Communications · 4
Development and validation of risk stratification models for hepatocellular cancer: A framework from the translational liver cancer consortium
2026 · Fasiha Kanwal, Ziding Feng, et al. · Hepatology · 1
Longitudinal Assessment of Clinical Risk Scores for Hepatocellular Carcinoma in Patients With Cirrhosis
2026 · Amit G. Singal, Camden Lopez, et al. · Clinical Gastroenterology and Hepatology
Towards early detection of pancreatic cancer: The current status of cohort studies by the Diabetes-Pancreatic Ductal AdenoCarcinoma Working Group
2026 · Anirban Maitra, Suresh T. Chari, et al. · Pancreatology
Abstract LB205: Dissociation between prediagnostic imaging phenotype and tumor biology defines the early detection challenge in pancreatic ductal adenocarcinoma
2026 · Khurram Khaliq Bhinder, Sovanlal Mukherjee, et al. · Cancer Research
Reply
2026 · Suresh T. Chari, Ziding Feng · Gastroenterology
Developing Performance-Guaranteed Biomarker Combination Rules with Integrated External Information under Practical Constraint
2026 · Osom, Albert, Lopez, Camden, et al. · arXiv (Cornell University)
PDF
Validation of Texas Hepatocellular Carcinoma Consortium Risk Index in the Hepatocellular Carcinoma Early Detection Strategy Study
2026 · Fasiha Kanwal, Camden Lopez, et al. · Clinical Gastroenterology and Hepatology
Works count: 8
Citation count: 5
H-index: 1
I10-index:
Year
Topic
Type